What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News The Ministry of Science and Innovation awards €4 million for the Phase 2b clinical trial with a new drug for ischemic stroke Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients. Activities PhD Training Programme 2024 i formació de gener En el marc de la HRS4R, i com una de les accions relacionades amb la formació i el desenvolupament professional, us presentem la programació del PhD Training Programme 2024. Aquest programa ha estat organitzat de forma conjunta per la Unitat d Activities Vall d'Hebron Talks 'Dona i VIH' Ponent: Dra. Paula Suanzes Díez, metgessa adjunta en el servei de Malalties Infeccioses des del 2019. Em dedico particularment al camp de la infecció per VIH i també treballo a l'àrea d'hospitalització i investigadora predoctoral del grup de recerca de Malalties infeccioses. Vall Hebron Institut News The pre-enrollment for the 11th edition of Translational Biomedical Research Master at VHIR is now open More than 400 students interested in acquiring knowledge and skills that will allow them to dedicate themselves to research aimed at finding solutions to people's health problems have already passed through the Master. Activities Inauguració de l'exposició 'Ultrasons, de la natura a la medicina' News Combination of antitumor drugs improves survival in patients with an aggressive type of pediatric cancer The BEACON clinical trial, in which Vall d'Hebron participates, has observed that adding Bevacizumab to treatment with different chemotherapy drugs reduces tumor size in a greater number of patients. News The Fortalece - Health program awards 2.4 million euros to Vall d'Hebron to promote research in chronic and minority diseases In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies. News VHIR participates in a European project to optimise AI and data analytics use in healthcare Phase IV AI is included in the Horizon Europe programme, lasts 3 years and prioritises data security and privacy compliance. News Work Led by Vall d'Hebron recognized in Third Edition of Esperanza Nacional Award for Research in Multiple Sclerosi Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article. Activities Retiment de Comptes de l'Hospital Universitari de Vall d'Hebron Vine al retiment de comptes de l'Hospital el pròxim 21 de desembre El pròxim dijous 21 de desembre, a les 13.00 hores Activities Vall d'Hebron Talks 'Sumant anys amb el VIH. Què hem de tenir en compte?' Ponent: Dr. Jordi Navarro Mercadé, metge especialista en Medicina Interna de l'Hospital Universitari Vall d'Hebron amb activitat centrada exclusivament a l'àrea de Malalties Infeccioses. La seva formació s'ha focalitzat a l'atenció a les persones amb VIH. Les seves àrees d'interès són la co News Interaction between the microbiota and the immune system influences the development of type 1 diabetes These are the results of a study published in Nature Communications and led by the Vall d'Hebron Research Institute (VHIR), the University of Lleida (UdL) and the Biomedical Research Institute of Lleida (IRBLleida). Activities Vall d'Hebron Talks by VHIR 'Cell therapy in transplantation: trials and tribulations' Speaker: Dr. Alberto Sánchez-Fueyo, MD PhD, is Professor of Hepatology, Academic Head of the Institute of Liver Studies at King’s College London, and Honorary Transplant Hepatology Consultant at King’s College Hospital. His research has focused on understanding the mechanisms of immunol News The Official College of Nurses of Barcelona funds two Vall d'Hebron research projects One study will improve the transition process of adolescents and, the other, will detect the risk of deterioration in hospitalised patients. News Inclusion of the optic nerve in the diagnostic criteria improves the detection of multiple sclerosis cases The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible. News Vall d'Hebron researchers participate in the revision of the McDonald diagnostic criteria for multiple sclerosis The meeting, held between November 29 and December 2 in Barcelona, brought together experts and opinion leaders in the field of multiple sclerosis from around the world. News Study identifies strategy to avoid resistance to cancer therapy A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs. Activities Retiment de Comptes Vall d’Hebron Institut de Recerca (VHIR) La Dra. Begoña Benito, directora del VHIR, us convida a compartir amb tot l'equip directiu, la sessió on es durà a terme el Retiment de Comptes del 2023, a la sala d'actes de la planta 10 de l'Hospital General el Activities Vall d'Hebron Talks by VHIR 'Trustworthy resources for data harmonization and analysis of brain stroke data' Speakers: Dr. Dragi Kocev and Dr. Panče Panov, department of Knowledge Technologies of the Jozef Stefan Institute, Ljubljana, Slovenia. News Vall d'Hebron participates in clinical trial to test a new gene therapy in patients with severe combined immunodeficiency The study, which is part of the European RECOMB project, is currently recruiting volunteers. Pagination First page « Previous page ‹ … Page 18 Page 19 Current page 20 Page 21 Page 22 … Next page › Last page »
